Market Research Blog – Page 8187 – New Product Development

Emission Control Catalyst Market Competitor Analysis, Winning Strategies and Growth Drivers 2031 – FMI

According to ESOMAR-certified consulting firm Future Market Insights’ (FMI), the global emission control catalyst market is projected to rise at above 10% CAGR, surpassing the market valuation of US$ 20.06 Bn during the forecast period 2021-2031.

As per Future Market Insights (FMI) analysis, the global emission control catalyst market is anticipated to expand at a 6.50% compound annual growth rate (CAGR) during the forecast period 2021-2031. The market valuation is projected to exceed US$ 8,070 Mn by 2031, registering the sales of 23,22,736 tons of emission control catalysts in 2021.

Expansion of the automotive industry, coupled with implementation of stringent government regulations regarding toxic gas emissions from vehicles and industries, is bolstering the demand for emission control catalysts.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-137

Increasing adoption of energy and fuel-efficient vehicles in developed regions such as the U.S., Germany and the U.K. will further boost the market growth in the upcoming decade.

The rising demand for lightweight passenger vehicles in developing regions such as China, Japan, India and Brazil will provide lucrative opportunities to the manufacturers operating in the market.

Key Takeaways from FMI’s Emission Control Catalyst Market Study

Palladium-based catalyst will dominate the product segment throughout the forecast period.
Demand in mobile equipment is anticipated to rise at a higher pace.
The U.S. will showcase high demand for emission control systems due to rising automobile sales.
The U.K. will emerge as a leading emission control catalyst market owing to implementation of stringent regulations and the presence of leading players.
Rising population and increasing adoption of new-energy vehicles across the country will bolster sales in China.
South Korea and Japan will account for approximately 7.50% of the total market share.

“Growing consumer preference towards energy-efficient vehicles, coupled with stringent government regulation regarding emissions will fuel the growth,” says the FMI analyst.

Competitive Landscape

Johnson Matthey, BASF SE, Haldor topsoe, Umicore, Corning Inc., Clariant AG, Zeolyst International, Heraeus Holding, Solvay SA, Cormetech, NGK Insulators Ltd., Aristo Global, Nett Technologies Inc. are some key players operating in the emission control catalyst market.

As per FMI’s analysis, key players are focusing on thorough research and development to enhance and expand their product portfolio.

Major players are also establishing tie-ups and targeting mergers and acquisitions with regional players for the expansion of their company, along with innovations in design and efficiency of their product range. For instance

In March 2019, Johnson Matthey launched a newly developed automatically regenerating Active DPF diesel particulate filter (DPF) system for stationary diesel engines, adding to the company’s robust portfolio.
In December 2018, the BASF SE opened a new site in Pudong, Shanghai, China for the product of its mobile emission catalysts, expanding the facility by more than 30,000 square meter to support the increased production.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-137

Emission Control Catalyst Market by Category

By Product Type

Diesel Based Emission Catalyst
Diesel Oxidation Catalyst (DOC)
Selective Catalytic Reduction Catalyst (SCR)
Catalyzed Soot Filter/ Diesel Particulate Filter
Ammonia Oxidation Catalyst (AMX)
NOx Adsorbers
Gasoline Based Emission Catalyst
Palladium based catalyst
Rhodium based catalyst
Platinum based catalyst

By Application

Mobile Equipment
Heavy-Duty Vehicles
Off-Road Vehicles
Passenger Cars & Light Duty Vehicles
Motorcycles, Scooters and Three Wheelers
Gardening Equipment
Stationary Equipment
Industrial Engines
Generators
Off-Road Equipment

By End Use

OEM
Retrofit

By Pollutant Type

Nox
CO
Hydrocarbons or Volatile Organic Compounds –
(HC/VOC)
HAPs
DPM (Diesel Particulate Matter)
NH3 (Ammonia)

By Region

North America
Latin America
Western Europe
Eastern Europe
China
Japan
India
South East Asia Pacific
MEA

Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-137

Key Points Covered in Emission Control Catalyst Market Survey

Market estimates and forecast 2021-2031
Key drivers and restraints impacting market growth
Segment-wise, Country-wise, and Region-wise Analysis
Competition Mapping and Benchmarking
Brand share and Market Share Analysis
Key Product Innovations and Regulatory Climate
COVID-19 Impact on Emission Control Catalyst Market market and how to Navigate
Recommendation on Key Winning Strategies

Top Reports Related To Automotive Market Insights

Electric Bike Market : Global electric bike market remains positive with the market value expected to increase at a CAGR of 3.1% during the forecast period (2017-2027).

Three Wheel E-Scooter Market : is anticipated to have a steady CAGR of 2.4% during the period 2022-2032 – Comprehensive Research Report by FMI

Water Proof E-Scooter Market : is anticipated to register a valuation of US$ 8.3 Bn by 2032 – Comprehensive Research Report by FMI

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Ischemic Cerebral Stroke Prevention Therapeutics Market Demand, Overview, Size, Trend, and Key Players

When an obstruction occurs in the blood vessel that supplies blood to the brain, it is known as ischemic stroke. This stroke accounts for around 87 percent of the total stroke cases and the main cause leading to ischemic stroke is uncontrolled hypertension. Basically, ischemic stroke is due to weak blood vessel, which gets rupture and leads to blood spill into the brain tissue.

There are two types of ischemic cerebral strokes namely embolic or thrombotic. During atherosclerosis, when artery is blocked by a blood clot, resulting into fatty deposits. However, when a blood clot is formed outside the brain and then travels to the blood stream, it is known as embolus (emboli) stroke. Globally, technological advancements leading to development of advanced surgical devices coupled with increasing prevalence of ischemic strokes among people has led to demand for better and efficient stroke management or treatment.

goal of ischemic cerebral stroke prevention to restore flow of blood as quickly as possible. Conventional ischemic stroke treatments include intravenous thrombolytic therapy and intra-arterial mechanical thrombectomy, which includes stent retriever devices. According to American Stroke Association, few recommendations related to prevention of ischemic cerebral stroke include sleep apnea screening, smoking cessation, and usage of anticoagulants orally especially patients suffering with non-valvular atrial fibrillation.

It is essential to prevent the stroke as this is the deadly condition and is an age related. This can be basically controlled in two ways, Primary Prevention of Stroke and the other is Secondary Prevention of Stroke.

Primary Prevention of Stroke can be done with the administration of antihypertensive drugs, anticoagulants-warfarin; antiplatelet agents, and statins. The prominent cause of Ischemic Cerebral Stroke are smoking, hypertension, Diabetes, Sickle cell disease, Body fat etc. There are also some home primary remedies like self-monitoring of blood pressure in hypertensive patients and proper sleep.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3236

Ischemic Cerebral Stroke Prevention Therapeutics Market: Drivers and Restraints

Increase in the number of cerebral stroke cases across the globe coupled with high prices for AIS therapy contribute towards significant growth of ischemic cerebral stroke prevention therapeutics market worldwide. In addition, growing prevalence of acute ischemic strokes among young population is anticipated to fuel the demand for surgical procedures, thereby in order to avoid the surgery demand for ischemic cerebral stroke prevention therapeutics will grow significantly in the next five to six years. However, limited availability of efficient drugs is restricting the market growth. Also, ischemic attack survivors are prone to another attack, thereby increased morbidity and mortality. This is leading to increased concerns for prevention therapeutics, resulting in overall ischemic cerebral stroke prevention therapeutics market growth.

Ischemic Cerebral Stroke Prevention Therapeutics Market: Overview

The global ischemic cerebral stroke prevention therapeutics market is expected to expand at healthy CAGR owing to increasing awareness for prevention of ischemic cerebral strokes prevention across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and low cost.

Ischemic Cerebral Stroke Prevention Therapeutics: Region-wise Outlook

Geographically, the global intravenous ultrasound systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for ischemic cerebral stroke prevention therapeutics. This is attributed to increasing cerebral stroke cases in the region. Geriatric population in Europe and Asia Pacific, who are prone to cerebral stroke offer opportunity for ischemic cerebral stroke prevention therapeutics market in the regions.

Ischemic Cerebral Stroke Prevention Therapeutics: Key Players

Key players operating in the global intravenous ultrasound systems market are Johnson & Johnson (Cordis Corporation), Boston Therapeutics, Inc., Edge Therapeutics, Inc., Zocere, Inc., Lundbeck, ThromboGenics, Vernalis, Bayer, Bristol-Myers Squibb, and Boehringer Ingelheim.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3236

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3236

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Malignant Infantile Osteopetrosis Market Trends, Demand Growth Revenue Analysis Report to 2027

Malignant Infantile osteopetrosis is also called as infantile autosomal recessive osteopetrosis. It is one of the rare skeletal dysplasia that is characterized using a radiographic pattern which shows increased bone density with involvement of the medullary portion. This type of disease typically manifests in infancy. Diagnosis of Malignant Infantile Osteopetrosis is based on radiographic evaluation and clinical evaluation, that is further confirmed using gene analysis technique if required.

Due to medullary canal eradication and bony expansion, cranial nerve compression, grave pancytopenia, and fractures may ensue. It condition of the patient becomes more critical if untreated for a longer time period. Defect in one or more genes that are involved in functioning, formation and development of cells leads to osteopetrosis.

This diseased condition involves some significant symptoms viz. blurring of vision, bone fractures, low blood cells level and recurrent dental infection.

The global Malignant Infantile Osteopetrosis Market is anticipated to register a significant CAGR over a forecast period. The increasing use of advanced diagnosis facilities such as DNA testing and bone marrow aspiration to diagnose the increasing prevalence of the osteopetrosis is the major factor, which anticipated to boost the growth of the global Malignant Infantile Osteopetrosis Market

The developing medical infrastructure and diagnostics facilities in the emerging markets such as China and India, also propel the growth of the global Malignant Infantile Osteopetrosis Market.

The increasing research and development activities to bring the new diagnostic technologies and up-gradation, also expected to drives the global Malignant Infantile Osteopetrosis Market over a forecast period. The increasing discretionary funding by the various governments and institutes for the research activities, also expected to boost the global market of the malignant infantile osteoporosis treatment and diagnosis over the forecast period.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3667

However, the higher cost associated with the diagnosis of the malignant infantile osteoporosis may hamper the diagnosis rate and restrain the growth of the global Malignant Infantile Osteopetrosis Market.

The low awareness about the malignant infantile osteoporosis and unavailability of advanced treatment in poorly developed economies, may also hamper the growth of the global Malignant Infantile Osteopetrosis Market over a forecast period.

On the basis of regional presence, the global Malignant Infantile Osteopetrosis Market is segmented into five key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.

Currently, North America is contributing the leading shares to the global Malignant Infantile Osteopetrosis Market in terms of value and anticipated to register a significant CAGR over a forecast period.

The Europe is also contributing the moderate shares to the market due to the availability of advanced diagnostic technologies in the region and the reimbursement policies. APAC is the most lucrative market for the malignant infantile osteoporosis diagnosis and expected to show a robust growth to the market due to increasing awareness about the malignant infantile osteoporosis and developing medical infrastructure.

MEA is at a nascent stage to the global Malignant Infantile Osteopetrosis Market and anticipated to register a decent growth to the market over a forecast period. Overall, the global Malignant Infantile Osteopetrosis Market is expected to show significant growth over a forecast period.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3667

Market Players

Some of the major market players in Malignant Infantile Osteopetrosis Market globally include GlaxoSmithKline plc., Pharmed Limited, Novartis International AG, Johnson & Johnson, Biocon Limited, InterMune, Inc., Pfizer Inc., Sanofi SA, Merck & Co., Inc. and many more.

The report covers exhaustive analysis on

Malignant Infantile Osteopetrosis Market segments
Malignant Infantile Osteopetrosis Market dynamics
Historical actual market size, 2014 – 2016
Malignant Infantile Osteopetrosis Market size & forecast 2017 to 2025
Niemann-Pick disease diagnosis current trends/issues/challenges
Competition & companies involved
Malignant Infantile Osteopetrosis Market drivers and restraints

Regional analysis includes

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3667

Malignant Infantile Osteopetrosis Market

The global Malignant Infantile Osteopetrosis Market is segmented on the basis of types of disease, type of test and end user.

On the basis of Medication type, the global Malignant Infantile Osteopetrosis Market is segmented into:

Vitamin-D supplements
Corticosteroids
Erythropoietin
Gamma interferon

On the basis of end user, the global Malignant Infantile Osteopetrosis Market is segmented into:

Hospital
Specialty Clinics
Research Centers

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Reprocessed Medical Devices Market Analysis, Industry Report, Trends, competitive Insights and Forecast 2027

Reprocessed medical devices are those devices are those devices that are refurbished and put to reuse again. The reprocessing of medical devices involves disinfection, cleaning, remanufacturing, testing, sterilization, packaging and labelling of the devices in order to put to service again.

The reprocessing of any medical device must follow a validated process which renders it fit for use. In order to reprocess the device factors like the efficacy, life cycle, potential risk to the patient and components used to manufacture the device are taken into consideration. With the increasing healthcare cost and high price of medical devices then demand for reprocessed medical devices is expected to witness high growth over the forecast period.

Reprocessed Medical Devices Market: Drivers & Restraints

The low price of the reprocessed devices is major factor responsible for the rising demand of the reprocessed medical devices, reprocessed medical devices cost nearly 30% – 40% less as compared to the new devices owing to which the demand for such devices is high in price sensitive low and middle income countries.

Hospitals are largest consumer segment of the reprocessed medical devices, with increasing number of hospitals and increasing pressure on the government hospitals to operate under limited budget and long term cost efficacy, adoption rate of the reprocessed medical devices is witnessing significant increase among the hospitals.

Strategic collaborations between manufacturers, end users and reprocessing companies is expected to boost revenue growth of the reprocessed medical devices market over the forecast period. Moreover several large hospitals are focusing on establishing in – house or outsourced reprocessing programs which in turn are expected to propel revenue growth.

For instance, in the U.S. there are nearly 3,000 hospitals with medical device reprocessing program. However the stringent laws for regulating the reprocessing of medical devices and technological restraints in the low income countries for reprocessing of the medical devices along with economic slowdown and tighter healthcare budgets are expected to hamper revenue growth of the reprocessed medical devices market over the forecast period.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2611

Reprocessed Medical Devices Market: Overview

The global reprocessed medical devices market is expected to witness robust growth over the forecast period owing to emphasis on reduction of medical waste, globally.

Moreover starting of reprocessing programs among large multispecialty hospitals is expected to push market growth over the forecast period. Government strategies to effectively control costs and increase profit margins is expected to propel revenue growth of the reprocessed medical devices market over the forecast period.

Reprocessed Medical Devices Market: Region – wise outlook

Regionally, global reprocessed medical devices market is divided in seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan (APEJ), Japan and Middle East and Africa (MEA)

North America is expected to be the largest marker in terms of production of reprocessed medical devices followed by Western Europe. The presence of government funded and privately held waste management and recycling companies and availability of advance technology for sanitization and reprocessing of the medical devices is expected to contribute to the revenue growth of the reprocessed medical devices market in these regions.

Based on consumption, Asia – Pacific region is expected to witness highest demand for reprocessed medical devices owing to price sensitive customer base and large population commanding demand for affordable medical devices. Latin America and MEA regions are also expected to witness high growth in the global reprocessed medical devices market owing to growing distribution network and strategic collaborations of the manufacturers in these regions.

Reprocessed Medical Devices Market: Market Participants

Some players in the global reprocessed medical devices market are Medline Industries, Inc., Stryker Sustainability Solutions, Integrity Medical Systems, Inc., Centurion Medical Products Corporation, Koninklijke Philips N.V., GE Healthcare, Siemens AG, and others.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-2611

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
APEJ (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2611

Reprocessed Medical Devices Market: Segmentation

Segmentation by Product Type

Cardiovascular Devices
Laparoscopic Devices
Orthopedic Devices
Gastroenterology Devices
General Surgery Devices

Segmentation by End User

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Chemotherapy-Induced Nausea And Vomiting Therapeutics Market Share 2017, Global Trends, Demand Factors And Outlook 2027

Cancer is a leading cause of death worldwide, accounting nearly 1.4 million new cases in 2012. The most common cause of cancer is lung cancer accounting about 1.59 million deaths, globally. Other prominent cancers are liver cancer, breast cancer, stomach cancer, esophageal and stomach cancer.

In 2012, nearly 8.2 million deaths occurred from aforementioned indication, globally. Cancer can be treated by surgery, chemotherapy, radiation therapy, hormone therapy, targeted therapy, precision medicine and stem cell transplantation.

The most common treatment for cancer is chemotherapy; it uses drugs to kill cancer cells that cause pain and other problems. Chemotherapy may be used in combination with other cancer treatments. Chemotherapy given before surgery and radiation therapy to make the tumor cell smaller is known as neo-adjuvant chemotherapy and chemotherapy given after treatment with surgery or radiation therapy is known as adjuvant chemotherapy.

Chemotherapy, not only kills the cancer cells but also attacks healthy cells that leads to side effects such as fatigue, hair loss, nausea, and vomiting. Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the most serious side effects that is taken into account.

Chemotherapy-induced nausea and vomiting are classified as acute, that occurs within 24 hours of the treatment; anticipatory, that is triggered due to some exposed stimuli; other are refractory; delayed and breakthrough. Incidence, timing, and intensity of chemotherapy-induced nausea and vomiting vary on chemotherapeutic agents and patient factors. CINV occurs in about 80% of patients and has a severe impact on patient’s life.

Antiemetics are less effective in controlling nausea and vomiting because the intensity is high than actual vomiting. Proper antiemetics can prevent CINV in about 60%-70% of patients. Nowadays due to research and development in the field of cancer therapeutics, many treatment options are available to manage and treat CINV by addressing antiemetic property to an individual patient.

Conventionally Chemotherapy-Induced Nausea and Vomiting was managed with dopamine receptor antagonists only. Currently, multiple options are available that is used in the prevention and management of CINV.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2957

Chemotherapy-induced Nausea and Vomiting Therapeutics Market: Drivers and Restrains

According to Word Health Organization, it is estimated that by 2030, about 23.6 million new cases of cancer will prevail worldwide. Agents are available for the treatment of chemotherapy-induced nausea and vomiting NK1 receptor antagonists, corticosteroids, -HT3 receptor antagonists and others.

Governmental guidelines from American Society of Clinical Oncology and National Comprehensive Cancer Network (NCCN /ASCO) are providing help to healthcare professionals to manage antiemetic regimens for patients. Intense research and development in cancer therapeutics, the rise in the incidence of cancer cases, increased preference toward chemotherapy for the treatment of cancer and the use of chemotherapy in combination with other cancer treatment are anticipated to fuel the growth of chemotherapy-induced nausea and vomiting.

The decline in the use of chemotherapy drugs in future can decline the growth of chemotherapy-induces nausea and vomiting therapeutics market.

Chemotherapy-induced Nausea and Vomiting Therapeutics Market: Overview

Based on the therapy type, the global chemotherapy-induced nausea and vomiting therapeutics market is segmented into dopamine antagonists, serotonin receptor antagonists, corticosteroids, benzodiazepines, and neurokinin NK1 receptor antagonist.

Serotonin receptor antagonists are said to account the major share in the chemotherapy-induced nausea and vomiting therapeutics market as it is most commonly used and is effective. It blocks the binding of serotonin to its receptor, thus stopping the signal to the brain.

By route of administration the chemotherapy-induced nausea and vomiting therapeutics market is segmented into oral and intravenous administration. Based on the distribution channel the CINV market is segmented into hospital pharmacy, drug store, retail pharmacy, and e-commerce.

The rise in cancer patient population, funding by the governmental bodies, focus on acquisition and merger by various key manufacturers is attributed towards the growth of chemotherapy-induced nausea and vomiting therapeutics.

Chemotherapy-induced Nausea and Vomiting Therapeutics Market: Regional Overview

Region-wise, the global Chemotherapy-induced Nausea and Vomiting Therapeutics Market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa.

More than 70% of world’s cancer death occurs in Africa, Asia, and South America. Around 33% of cancer cases worldwide are due to smoke and tobacco. Along with expansion in the emerging markets, and a greater focus on early diagnosis, screening, monitoring and clinical development of CINV drugs have been the major strategies adopted by major players in the global chemotherapy-induced nausea and vomiting therapeutics market.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-2957

Chemotherapy-induced Nausea and Vomiting Therapeutics Market: Key Players

Some of the key players in global Chemotherapy-induced Nausea and Vomiting Therapeutics Market are GlaxoSmithKline plc, Merck & Co., Inc, Teva Pharmaceuticals, Heron Therapeutics, Inc., F. Hoffmann-La Roche AG, Tesaro, Inc., Acacia Pharma, Baxter international Inc., Lee’s Pharmaceutical Holdings, Mundipharma International limited, Kyowa Hakko Kirin Co., Ltd.and others.

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)

The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2957

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Autoimmunity Immunoassay Market Size, Share, Growth, Trends, Industry Analysis | 2027

The immune system of human body acts against foreign materials and help in protecting body. However, sometimes this immune system acts against own tissues or cells as foreign material and results in autoimmunity or autoimmune disease. Autoimmunity is chronic inflammatory condition which can be either organ specific or systemic in nature.

According to a report from National Institute of Health autoimmune conditions are one of the top ten cause of death among female children and women of age up to 64 years, and there are at least 80 human conditions which are caused by autoimmune responses. Test which is normally used for diagnosis of autoimmunity is called as immunoassay. Immunoassay is a diagnostic test that uses the reaction of antibody against antigen to diagnose autoimmunity.

Autoimmunity Immunoassay Market: Drivers and Restraints

The major factor driving the growth of autoimmunity immunoassay market is rising incidence of autoimmune disease. Other factors which are driving the growth of this market are increasing awareness among people regarding, cost-effectiveness and rapidness in detecting autoimmunity. Higher accuracy and government initiate are also driving the growth of autoimmunity immunoassay market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3562

Autoimmunity immunoassay maker is expected to show significant growth over the forecast period. Immunoassay methods are highly sensitive and rapid in determining the autoimmunity. Reagent product segment is expected to be highest and fastest growing segment due to cost effectiveness and focus of major players on development of reagent immunoassay kits.

Enzyme linked immunosorbent assay account for the largest share in the global autoimmunity immunoassay market due to its high accuracy, cost effectiveness and this method has been used for a long time. But Chemiluminescence immunoassay is expected to be fastest growing due to due to ultra-sensitivity of this method and can be used to detect small amount of molecule or autoantibody.

Increasing awareness and adoption of this method is also expected to be growth driving factor. Other factors which are expected to drive the growth of autoimmunity immunoassays market are increasing demand of rapid results of test, highly accurate results and increasing drug discovery for autoimmune diseases.

Autoimmunity Immunoassay Market: Region Wise Outlook

Geographically, global autoimmunity immunoassay market can be segmented into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. North America is most attractive autoimmunity immunoassay market due to the better healthcare infrastructure and technological advancements.

Followed by which is Europe. Presence of key players in these regions and higher awareness among people regarding autoimmunity is reason for higher revenue generation. Asia-Pacific market is expected to be fastest growing market due to increasing no of diagnostic laboratories, improving healthcare infrastructures and government initiative to spread awareness among people regarding the auto-immune disease.

Availability of huge opportunity in this region is also driving the growth.

Autoimmunity Immunoassay Market: Key Players

Some of the market participants in the global autoimmunity immunoassay market are Siemens Healthcare GmbH, Akers Biosciences, Inc., Biomerieux SA, Thermo Fisher Scientific, Enzo Life Sciences, Inc., Eiaab Hong Kong Company Limited, Beckman Coulter, Inc. and Diasorin S.P.A. Focus of these companies are on development of the reagent kits for diagnosis of autoimmunity.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3562

The report covers exhaust analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3562

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Wound Irrigation Devices Market Production, Growth, Share, Demand and Applications Forecast to 2027

Wound irrigation devices are used in wound healing treatment. Wound irrigation is an often overlooked dynamic to wound care essentially because the importance of keeping a wound hydrated is under appreciated. When a wound is not receiving some fluids it needs, the primary recovery process of inflammation, cell migration and reformation of granulation tissue slows down, significantly increasing the chances of wound infection.

Irrigating wound injury also helps with debridement, so excess dead or healthy tissue becomes easier to remove. Various types of solutions available to irrigate wound and method of solution delivery to the wound. Compared to swabbing or bathing, wound irrigation is considered to be the most consistently effective method of wound cleansing.

Wound irrigation devices market: Drivers and Restraint

Improving efficiency of wound care products,Reducing wound bioburden can help improve healing time, which can lead to shorter hospital stays and lower the overall cost of care, rising awareness of advancement in wound healing therapy such as types of dressings and different treatment available in current market are the key factors which work as a driver for wound irrigation devices market.

However, poor regulatory acts for the use of wound irrigation technologies and improved wound prevention techniques are some of the key factors restraining the wound irrigation devices market.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3554

Wound irrigation devices Market: Overview

Wound irrigation devices market is emerging as the incidence and prevalence of the various type of wounds such as chronic wounds, acute wounds, and others are growing fast around the world. Important factors such as the incident of accidents, various sports injuries, increase in adoption rate, which are drives the wound irrigation devices market.

Global wound irrigation devices market grows surprising due to the cumulative tendency of public towards expenditure improved wound irrigation care rather than traditional wound healing treatment. Increasing cognizance of wellness, quality of hygiene and health within the public.

Top companies in the wound irrigation market are financing largely in educating people about the profits of wound irrigation, which further helps to expand the wound irrigation market.

Wound irrigation devices Market: Region-wise Outlook

North America leads the global wound irrigation devices market share followed by Europe, because of increasing no of incident and prevalence of patients with the various wound such as the incident of an accident, increasing no of diabetes patients, developed health care expenditure, rising aging population.

Europe shows profitable market as the adoption rate of wound irrigation devices due to growing prevalence of diabetes patients, acute and chronic wound cases and burns cases. Asia Pacific is emerging market for wound irrigation devices due to increase in point of care approach to health & care. Increasing no of hospitals in India and China makes the promising market for wound irrigation devices market worldwide.

Wound irrigation Devices Market: Key Market Participants

Some of the major players stand in global wound irrigation devices market Aurena laboratories, cooper surgical, Bionix, B Braun, Fresenius SE & Co, Hollister wound care, Smithy & Nephew Plc, etc.

The research report provides analysis and information according to market segments such as geographies, application, and industry.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3554

The report covers exhaust analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

The regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
The Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3554

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Micro-Ultrasound Systems Market Future Demands, Regional Developments and Industry Competitive Landscape Analysis

Micro-ultrasound systems market is a growing market as the preclinical research on cancer and imaging modality are taking place in research institution and pharmaceutical industries. As the traditional ultrasound is used for imaging, as of micro-ultrasound system are used to analyze diseases in human.

Micro-ultrasound system give a platform to monitor the tumor volume changes, angiogenesis and also help in monitoring the ECG, heart rate and the body temperature of animals. As micro-ultrasound is the small version of technique traditional ultrasound, it’s very helpful in studying the smaller animal model, this smaller imaging has also reduce the number of animals required for the clinical research.

Micro-ultrasound is capable of anatomical imaging. Micro-ultrasound systems generate the sound waves from transducers and penetrate the living tissue for getting the image in 2D or 3D. Micro-ultrasound are very useful for studies smaller animal for research purpose as the range of micro-ultrasound is from 15-20 MHz Micro-ultrasound also helps in early detection of tumor in the body ranging from 50 µm or above.

Micro-ultrasound has many application which enable the micro-injection of drug, detection and measure the cardiotoxicity for cancer therapy and other probes into tumors. The diverse application of micro-ultrasound creates significant opportunities in the diagnostics and treatment procedures.

Micro-ultrasound Systems Market: Drivers and Restraints

Micro-ultrasound systems providing the evidential support to the clinical research. Micro-ultrasound visualize the tiny tumor vasculature the image resolution. Micro-ultrasound has the unique property of in-vivo detection and analysis with a high-resolutions in real time imaging. Penetration of micro-ultrasound systems are lesser when compared with micro-MRI, and micro-CT.

However, micro-ultrasound system are ease to use, portable in nature and cost-effective are expected to drive the growth of the market over the forecast period.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3524

Micro-ultrasound Systems Market: Overview

Micro-ultrasound systems market is one of the fastest growing market for preclinical imaging in different area of research like cancer, vascular disease, stem cell and others. Micro-ultrasound is cost effective as compared with other systems, further image resolutions are also increases by injection microbubbles contrast agents. The user of micro-ultrasound get the raw data which is not available with other traditional ultrasound systems.

For instance, in June 2006 between FUJFILM VisualSonics Inc. and Bracco Group entered a partnership agreement to develop and manufacture of MicroMarkerTM contrast agents optimized for preclinical imaging on VisualSonic’Vevo 770 micro-ultrasound platform.

Recently one of the player name as Exact Imaging has received approval in March 2017 from Health Canada and the license (#98667) to sell micro-ultrasound in Canada. The ExactVuTM product of Exact Imaging is used by urologist to visualized and distinguish suspicious cancer tissue and allow to target prostate biopsies.

Micro-ultrasound Systems Market: Region-wise Outlook

On the basis of region, Micro-ultrasound Systemsis segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, Japan, Middle East and Africa. North America and Western Europe are the growing market as most of the players are present in this region and working on the technology enhancement with respect to size of the system and use in different preclinical research. Asia Pacific is a potential market as many of research institute and pharmaceutical industry have their present and using micro-ultrasounds systems.

Micro-ultrasound Systems Market: Key Players

Some of the players are Exact Imaging, FUJFILM VisualSonics Inc., Carestream Health, and Hitachi Medical Systems.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3524

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil and Rest of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3524

Micro-ultrasound Systems Market: Segmentation

Micro-ultrasound system market segmentation based on:

Based on Application:

Cancer research or tumor volume
Lesion detection
Drug efficacy

Based on imaging technique:

Non-invasive imaging
In-vivo imaging

Based on end users:

Clinical research institutes
Pharmaceutical and Biotechnology Industries
Diagnostics centers

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Ocular Implants Market Trends, Overview, Industry Growth And Forecast To 2027

Ocular implants are medical devices which are designed to replace the damaged visual organ or helps in restoring vision sharpness. There are several types of implants available in the market to treat varied eye diseases or disorders. Implants like Intraocular Lenses (IOL), corneal implants, implants for glaucoma surgery, etc. are used to augment the damaged to missing visual organs.

Ocular prosthesis is type of implant where part of eye supplied to treat the deficiency. The prosthetic eye are available in customized and stock forms according to the eye dimensions. Majority of the implants made from high grade plastics which are compatible to the eye. Few ocular implants serve as drug delivery systems in treatment of Uveitis, other posterior eye segments diseases.

Ocular Implants Market: Drivers and Restraints

Global ocular implants market is continue to witness positive growth owing to increased cataract development over the age of 65, increasing life expectancy and rising geriatric population would expected to fuel demand ocular implants over a period of forecast. The market for ocular implants driven by technological advances in implants like multifocal intraocular lens technology and rising awareness about aesthetics among young patient population expected to fuel the market for ocular implants over a period of forecast.

However, potential side effect or damage associated with use of ocular implants to the eye, dearth of skilled workforce to perform the implantation procedures may hamper the growth of the ocular implants market over a period of forecast.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-3448

Ocular Implants Market: Overview

Global ocular implants market is highly fragmented with several local and international players offering different implantable products in the marketplace. Players or service providers in the ocular implants market is coming up with customized solution that addresses the patient requirements. Players in ocular implants market is developing newer designs which are influenced by viscoelastic technology and others to gain larger market revenue share in the ocular implants market.

In ocular implants market, implant segment like Intraocular Lenses (IOL) expected to witness significant growth over a period of forecast. Moreover, end users (Service providers) in the market continuously working towards educating the patients regarding implantation surgeries and post-surgery precautions.

Ocular Implants Market: Region-wise Outlook

Geographically, ocular implants market is segmented into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe will remain key markets for ocular implants market. Developed markets like North America and Europe is expected to witness robust growth owing to increased number of eye surgeries, presence of key players in the region. Moreover, key players in theocular implants market are majorly focusing on both developed and developing regions markets to tap the increased market demand for ocular implants. Asia Pacific is anticipated to register positive growth owing to favourable patient demographics and developing healthcare infrastructure in the region.

Ocular Implants Market: Key Players

Some players in ocular implants market include Johnson & Johnson Services, Inc., Alcon (Novartis AG), Bausch & Lomb Incorporated., Pfizer Inc., MORCHER® GmbH, and STAAR SURGICAL to name a few.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-3448

The report covers exhaustive analysis on

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil and Rest of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-3448

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Bone Metabolism Test Market Key Players, SWOT Analysis, Key Indicators, Forecast and COVID 19 Impact Analysis 2027

Conflicting to the repeatedly held misinterpretations, bone is a comparatively active organ that experience notable changes as contrast to other organs in the body. Bone metabolism is related with diseases impacting bone and mineral metabolism that includes a wide range of skeletal and soft tissue infection.

In general, these infections may be combined as Paget disease of bone, osteoporosis, developmental disorders of bone and hyperparathyroidism. Geriatric population that is nearby 28 million in America get influenced by osteoporosis, and the fetch to treat for osteoporosis-associated fractures was evaluated to be about $14.8 billion every year a short time before.

Other metabolic bone diseases are comparatively lacking, but anyhow are a source of notable cost to society and morbidity. Bone is a specific tissue intended to deliver enough potency to resist involuntary forces, but still to be light enough to permit flexibility. It has a complicated composition and experience constant remodeling or metabolism.

To treat bone metabolism diseases there are several tests available in market and cost for treatment is much higher as most of the population in the world is threatened by bone metabolism diseases the market will drive towards growth for bone metabolism tests.

On the basis of test types global bone metabolism test market can be segmented into bone marker test and immunoassay where, bone markers are related with biochemical marker that specify breakdown of bone that can be used to estimate individual’s bone fracture risk at the moment when density of mineral measurement does not specify the results and immunoassay is related with a laboratory technique that recognize and evaluate a protein like hormone or enzyme based on capacity to act as an antibody or antigen in chemical reaction.

Request Sample PDF Brochure:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-2721

Furthermore, Bone marker tests are categorized into C-Telopeptide marker test, P1NP marker test, N- telopeptide marker test and osteocalcin test. C-Telopeptide marker test used to monitor anti-restoratives therapies like hormone replacement therapy in people with low bone mass and in women with menopause and is peptide fragment from the carboxyl terminal end of the protein matrix. P1NP Marker is for bone formation occurred from osteoblast and it is recommended that the test should be performed before the treatment of osteoporosis and again after 3 to 6 months.

N-telopeptide is a peptide fragment used to monitor another marker therapy from amino terminal end of the protein matrix and osteocalcin is form of protein formed by osteoblast this test may be simulated by using drug warfarin. Moreover, Immunoassay is categorized into ELISA and RIA where enzyme-linked immunosorbent assay (ELISA) is used to detect the presence of antibody and antigen through a biochemical mechanism and radioimmunoassay (RIA) is in-vitro assay technique to detect antigen in the body with the help of antibody present in the body.

On the basis of application types global bone metabolism test market is segmented into hyperparathyroidism, hypoparathyroidism, osteoporosis, Paget’s disease and kidney disease. Hyperparathyroidism mostly occur in people having age more than 50 while neonatal or new born babies are highly threatened by hypoparathyroidism.

Osteoporosis has dominated the market in bone metabolism diseases and is the most common disease occurring in women on in tenth will have osteoporosis at the age of 60, more than 8.9 million fractures are recorded yearly due to osteoporosis throughout the world. Rising penetrance rate of osteoporosis is driving the bone metabolism test market towards the growth in the forecast period. Paget’s disease is most common in men than women in that bone growth is too large and weak.

Inquire Before Buying Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-2721

On the basis of geography, global bone metabolism test market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and Middle East Africa.

North America and Latin America are the dominating market in global bone metabolism test market followed by Europe as penetrance of osteoporosis, hyperparathyroidism is increasing in large amount. Asia pacific and Middle East Africa is rising market for bone metabolism test market as volume has increased in last few years. Hence, companies are making strategies to enter in the market.

Some of the major players in global metabolism test market are: Siemens Healthcare GmbH, F. Hoffmann-La Roche, Abbott GmbH & Co. KG, DiaSorin, bioMerieux SA and Quidel Corporation. Siemens Healthcare GmbH Has largest market share in bone metabolism test market. The increasing competition in key players to develop new therapy and technology for bone metabolism test will drive the market globally.

The report covers exhaustive analysis on

Bone Metabolism Test Market Segments
Bone Metabolism Test Market Dynamics
Historical Actual Market Size, 2013 – 2015
Bone Metabolism Test Market Size & Forecast 2017 to 2027
Bone Metabolism Test Market Current Trends/Issues/Challenges
Competition & Companies involved
Bone Metabolism Test Market Drivers and Restraints

Regional analysis includes

North America
Latin America
Europe
Asia Pacific
Middle East & Africa

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-2721

About Future Market Insights, Inc.

Contact Us:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs